News Detail

Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday

Benzinga · 04/28 14:27

Listen to the news

U.S. stocks were mostly higher, with the Dow Jones index gaining around 200 points on Monday.

Shares of CEMEX, S.A.B. de C.V. (NYSE:CX) rose sharply during Monday's session following first-quarter results.

The company reported first-quarter net sales of $3.65 million, missing the consensus of $3.80 billion. Net sales fell 7% year over year (Y/Y), mainly due to lower volumes in Mexico. EBITDA declined 18% Y/Y to $601 million in the quarter, with a margin contracted 2.0ppt Y/Y to 16.5% in the quarter.

Cemex expects recurrent yearly EBITDA savings of at least $150 million in 2025 and $350 million by 2027.

Cemex shares jumped 4.2% to $6.16 on Monday.

Here are some other big stocks recording gains in today's session.

Plug Power Inc. (NASDAQ:PLUG) shares jumped 39.4% to $1.13 after the company signed a secured credit facility with Yorkville Advisors. The company also reported preliminary first-quarter results.
CG Oncology, Inc. (NASDAQ:CGON) surged 30% to $29.02 after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American Urological Association Annual Meeting.
Wolfspeed, Inc. (NYSE:WOLF) rose 24.5% to $4.07.
Sabre Corporation (NASDAQ:SABR) gained 20.3% to $2.6350 as the company entered into definitive agreement to sell its Hospitality Solutions business unit to TPG for $1.1 billion.
Pony AI Inc. (NASDAQ:PONY) rose 17.4% to $8.23.
TMC the metals company Inc. (NASDAQ:TMC) gained 15.9% to $3.5350.
Rapport Therapeutics, Inc. (NASDAQ:RAPP) climbed 12.6% to $11.96.
VEON Ltd. (NASDAQ:VEON) gained 12.2% to $47.83.
ADMA Biologics, Inc. (NASDAQ:ADMA) rose 12% to $24.49 as the company announced the FDA approval of its yield enhancement production process.
Summit Therapeutics Inc. (NASDAQ:SMMT) gained 10% to $25.79.
UroGen Pharma Ltd. (NASDAQ:URGN) gained 10% to $10.85 after the company highlighted nearly four-year duration of response in OLYMPUS long-term follow-up study of JELMYTO.
Aurora Innovation, Inc. (NASDAQ:AUR) rose 7.6% to $7.41.
Hims & Hers Health, Inc. (NYSE:HIMS) gained 6.1% to $29.82.
Peloton Interactive, Inc. (NASDAQ:PTON) rose 5.4% to $6.63. Truist Securities analyst Youssef Squali upgraded Peloton Interactive from Hold to Buy.

Now Read This:

Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.